Patient reported outcome questionnaires

BEHAVIORAL2 trials

Sponsors

MacroGenics, Stanford University

Conditions

Type 1 Diabetes MellitusType 2 Diabetes

Unknown Phase

Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)

TerminatedNCT00870818

MacroGenicsType 1 Diabetes Mellitus

Start: 2009-02-28End: 2011-05-31Updated: 2023-08-09

Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study

CompletedNCT05074667

Stanford UniversityType 2 Diabetes

Start: 2021-12-01End: 2023-06-25Updated: 2024-07-31

Related Papers

Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study

Journal of Diabetes Science and Technology2025-09-20

Sicherheit von Teplizumab bei Typ-1-Diabetes im Stadium 2 und Stadium 3: Integrierte Analyse klinischer Studien

Diabetologie und Stoffwechsel2025-05-01

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01